Moreover, mutations have been identified in several genes involved in the PI3K/AKT/mTOR pathway (e.g., PIK3CA, PTEN, AKT, RICTOR, and mTOR) in SCLC [15]. This evidence concerns the gene MTOR and small cell lung carcinoma.